413 related articles for article (PubMed ID: 30144842)
21. Aging and androgens: Physiology and clinical implications.
Anawalt BD; Matsumoto AM
Rev Endocr Metab Disord; 2022 Dec; 23(6):1123-1137. PubMed ID: 36459352
[TBL] [Abstract][Full Text] [Related]
22. Hypoandrogenism in association with diminished functional ovarian reserve.
Gleicher N; Kim A; Weghofer A; Kushnir VA; Shohat-Tal A; Lazzaroni E; Lee HJ; Barad DH
Hum Reprod; 2013 Apr; 28(4):1084-91. PubMed ID: 23427231
[TBL] [Abstract][Full Text] [Related]
23. Oral enclomiphene citrate raises testosterone and preserves sperm counts in obese hypogonadal men, unlike topical testosterone: restoration instead of replacement.
Kim ED; McCullough A; Kaminetsky J
BJU Int; 2016 Apr; 117(4):677-85. PubMed ID: 26496621
[TBL] [Abstract][Full Text] [Related]
24. [Female hyperandrogenemia and normal serum levels of testosterone and sex hormone binding globulin].
Danilowicz K; Bruno OD; Mana D; Serra HA; Cross G; Rey JA
Medicina (B Aires); 2014; 74(5):359-62. PubMed ID: 25347896
[TBL] [Abstract][Full Text] [Related]
25. Helpful diagnostic markers of steroidogenesis for defining hyperandrogenemia in hirsute women.
Willenberg HS; Bahlo M; Schott M; Wertenbruch T; Feldkamp J; Scherbaum WA
Steroids; 2008 Jan; 73(1):41-6. PubMed ID: 17915271
[TBL] [Abstract][Full Text] [Related]
26. Modified dexamethasone and gonadotropin-releasing hormone agonist (Dx-GnRHa) test in the evaluation of androgen source(s) in hirsute women.
Bidzińska B; Tworowska U; Demissie M; Milewicz A
Przegl Lek; 2000; 57(7-8):393-6. PubMed ID: 11109312
[TBL] [Abstract][Full Text] [Related]
27. Effects of metformin therapy on hyperandrogenism in women with polycystic ovarian syndrome.
Kazerooni T; Dehghan-Kooshkghazi M
Gynecol Endocrinol; 2003 Feb; 17(1):51-6. PubMed ID: 12724019
[TBL] [Abstract][Full Text] [Related]
28. Sexual dichotomy of gonadal function in Prader-Willi syndrome from early infancy through the fourth decade.
Hirsch HJ; Eldar-Geva T; Bennaroch F; Pollak Y; Gross-Tsur V
Hum Reprod; 2015 Nov; 30(11):2587-96. PubMed ID: 26345685
[TBL] [Abstract][Full Text] [Related]
29. Prevalence of dermatologic manifestations and metabolic biomarkers in women with polycystic ovary syndrome in north China.
Feng JG; Guo Y; Ma LA; Xing J; Sun RF; Zhu W
J Cosmet Dermatol; 2018 Jun; 17(3):511-517. PubMed ID: 28940857
[TBL] [Abstract][Full Text] [Related]
30. Establishing the cut off values of androgen markers in the assessment of polycystic ovarian syndrome.
Nadaraja RND; Sthaneshwar P; Razali N
Malays J Pathol; 2018 Apr; 40(1):33-39. PubMed ID: 29704382
[TBL] [Abstract][Full Text] [Related]
31. A Comparison of the Hormonal Profile of Early Androgenetic Alopecia in Men With the Phenotypic Equivalent of Polycystic Ovarian Syndrome in Women.
Sanke S; Chander R; Jain A; Garg T; Yadav P
JAMA Dermatol; 2016 Sep; 152(9):986-91. PubMed ID: 27304785
[TBL] [Abstract][Full Text] [Related]
32. Loss of lean body and muscle mass correlates with androgen levels in hypogonadal men with acquired immunodeficiency syndrome and wasting.
Grinspoon S; Corcoran C; Lee K; Burrows B; Hubbard J; Katznelson L; Walsh M; Guccione A; Cannan J; Heller H; Basgoz N; Klibanski A
J Clin Endocrinol Metab; 1996 Nov; 81(11):4051-8. PubMed ID: 8923860
[TBL] [Abstract][Full Text] [Related]
33. Screening for Hypogonadism in Primary Healthcare: How to do this Effectively.
Livingston M; Jones R; Hackett G; Donnahey G; Moreno GY; Duff CJ; Heald AH
Exp Clin Endocrinol Diabetes; 2018 Mar; 126(3):176-181. PubMed ID: 29365335
[TBL] [Abstract][Full Text] [Related]
34. Endocrine Society of Australia position statement on male hypogonadism (part 1): assessment and indications for testosterone therapy.
Yeap BB; Grossmann M; McLachlan RI; Handelsman DJ; Wittert GA; Conway AJ; Stuckey BG; Lording DW; Allan CA; Zajac JD; Burger HG
Med J Aust; 2016 Aug; 205(4):173-8. PubMed ID: 27510348
[TBL] [Abstract][Full Text] [Related]
35. Optimal diagnostic measures and thresholds for hypogonadism in men with HIV/AIDS: comparison between 2 transdermal testosterone replacement therapy gels.
Blick G
Postgrad Med; 2013 Mar; 125(2):30-9. PubMed ID: 23816769
[TBL] [Abstract][Full Text] [Related]
36. Male hypogonadism : an update on diagnosis and treatment.
Darby E; Anawalt BD
Treat Endocrinol; 2005; 4(5):293-309. PubMed ID: 16185098
[TBL] [Abstract][Full Text] [Related]
37. Prevalence of undiagnosed testosterone deficiency in aging athletes: does exercise training influence the symptoms of male hypogonadism?
Di Luigi L; Sgrò P; Fierro V; Bianchini S; Battistini G; Magini V; Jannini EA; Lenzi A
J Sex Med; 2010 Jul; 7(7):2591-601. PubMed ID: 20141589
[TBL] [Abstract][Full Text] [Related]
38. Current guidelines for the diagnosis of testosterone deficiency.
Arver S; Lehtihet M
Front Horm Res; 2009; 37():5-20. PubMed ID: 19011285
[TBL] [Abstract][Full Text] [Related]
39. [Hyperandrogenism after menopause: Ovarian or adrenal origin?].
Sarfati J; Moraillon-Bougerolle M; Christin-Maitre S
Gynecol Obstet Fertil Senol; 2022 Oct; 50(10):675-681. PubMed ID: 35609786
[TBL] [Abstract][Full Text] [Related]
40. Increased anti-Mullerian hormone levels and ovarian size in a subgroup of women with functional hypothalamic amenorrhea: further identification of the link between polycystic ovary syndrome and functional hypothalamic amenorrhea.
Carmina E; Fruzzetti F; Lobo RA
Am J Obstet Gynecol; 2016 Jun; 214(6):714.e1-6. PubMed ID: 26767792
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
